Effect of obesity on COVID-19 disease severity in children

Yakup Çağ1, Ayşe Karaaslan2, Aslı A Çıkrıkçıoğlu1

  • 1Department of Pediatrics, University of Health Sciences, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Türkiye.

Insights

Obese children experience more COVID-19 symptoms and lung involvement, indicating a more severe disease course. This study highlights obesity as a significant risk factor in pediatric COVID-19 cases.

Area of Science:

  • Pediatric Infectious Diseases
  • Public Health
  • Metabolic Disorders

Background:

  • Coronavirus disease 2019 (COVID-19) has led to significant global morbidity and mortality.
  • Obesity is a recognized risk factor for severe COVID-19, but mechanisms in children remain unclear.
  • Understanding the impact of pediatric obesity on COVID-19 severity is crucial for public health strategies.

Purpose of the Study:

  • To investigate the association between obesity and overweight status and the clinical course of COVID-19 in pediatric patients.
  • To determine if body mass index (BMI) influences symptom presentation and disease severity in children with COVID-19.
  • To identify potential BMI thresholds associated with increased risk of lung involvement in pediatric COVID-19.

Main Methods:

  • Retrospective analysis of 116 pediatric patients (under 18) with confirmed COVID-19 infection.
  • Data collected included demographics, symptoms, anthropometrics (weight, height), chest radiographs, laboratory results, and hospitalization duration.
  • Patients were categorized into underweight, normal weight, overweight, and obese groups based on BMI percentiles for statistical comparison.

Main Results:

  • Overweight and obese children exhibited a higher incidence of COVID-19 symptoms compared to normal-weight and underweight children (p < 0.05).
  • Obese pediatric patients demonstrated a significantly higher rate of lung involvement on chest radiographs (p < 0.05).
  • A BMI percentile cutoff of >91 was identified as optimal for predicting lung involvement in pediatric COVID-19 cases.

Conclusions:

  • Obesity in children is associated with increased symptom frequency during COVID-19 infection.
  • Obese children are more prone to lung involvement, suggesting a more severe disease trajectory.
  • These findings underscore the importance of managing pediatric obesity to mitigate risks associated with COVID-19.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
383
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
756
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
235
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.5K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K